The Hill
Wednesday, November 19, 2008
SEARCH
Home
HillTube
Mobile
White Papers Portal
New Member Guide
BLOGS
Pundits Blog
Congress Blog
Blog Briefing Room
NEWS
Leading The News
Business & Lobbying
K Street Insiders
John Breaux
John Engler
Vin Weber
Dave Wenhold
The Executive
Campaign 2008
Endorsements '08
COLUMNISTS
Dick Morris
A.B. Stoddard
Brent Budowsky
Ben Goddard
David Hill
David Keene
Josh Marshall
Mark Mellman
Jim Mills
Markos Moulitsas (Kos)
Byron York
COMMENT
Editorial
Letters
Op-eds
Weyant's World
CAPITAL LIVING
Today's Stories
50 Most Beautiful 2008
Other Features
In The Know
Bookshelf
Food & Drink
Onward and Upward
Hillscape
RESOURCES
Classifieds
Subscribe
Order Reprints
Last Six Issues
Useful Links
RSS


Home arrow Leading The News arrow Drug imports amendment passes, with strings attached
Leading The News PDF Print E-mail
Drug imports amendment passes, with strings attached
Posted: 05/07/07 06:14 PM [ET]
The Senate Monday approved language designed to permit the importation of less expensive medications from abroad, but not before attaching language opposed by supporters of “reimportation.”

Sen. Byron Dorgan’s (D-N.D.) amendment to a Food and Drug Administration (FDA) bill passed by voice vote Monday, following a 63–28 cloture vote on the language last Thursday. Dorgan’s legislation would allow individuals and wholesalers to import drugs from other countries for sale in the United States.

But Dorgan and his allies were unable to beat back legislation sponsored by Sen. Thad Cochran (R-Miss.), which was favored by the Senate Republican leadership and the drug industry. Cochran’s measure would require the Department of Health and Human Services (HHS) to certify the safety of drugs brought in from abroad. The Cochran amendment passed 49–40.

The White House indicated last week that President Bush would veto any bill that contained reimportation provisions. The addition of the Cochran language, however, may free the president from rejecting the entire FDA bill. During both the current and Clinton administrations, HHS refused to guarantee that it could certify the safety of drugs imported from other countries.

Following the votes, senators were poised to vote on final passage of the underlying vehicle, which would reauthorize programs through which the pharmaceutical and medical device industries pay user fees to the FDA for reviews of their new products.

 
 
 
BLOGS
ADVERTISER
Home | Privacy Policy | Terms And Conditions
The Hill
1625 K Street, NW Suite 900
Washington, DC 20006
202-628-8500 tel | 202-628-8503 fax

The contents of this site are © 2008 Capitol Hill Publishing Corp., a subsidiary of News Communications, Inc.